Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer

Jiang,Lili; Liang,Xuan; Liu,Mengjie; Wang,Wenjuan; Ma,Jiequn; Guo,Qianqian; Han,Lili; Yang,Chengcheng; Nan,Kejun

doi:10.3892/or.2014.3432

Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer

Authors:
- Lili Jiang
- Xuan Liang
- Mengjie Liu
- Wenjuan Wang
- Jiequn Ma
- Qianqian Guo
- Lili Han
- Chengcheng Yang
- Kejun Nan
View Affiliations

Affiliations: Department of Oncology, The First Affiliated Hospital of the Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: August 21, 2014 https://doi.org/10.3892/or.2014.3432
Pages: 1931-1938

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver kinase B1 (LKB1) regulates cell polarity and has tumor-suppressor functions, while Beclin1 regulates autophagy and is associated with tumorigenesis. The present study quantified the expression level of LKB1 and Beclin1 in non-small cell lung cancer (NSCLC) tissue specimens and examined the possible association with clinicopathological characteristics and the survival of patients. Quantitative real-time reverse transcriptase‑polymerase chain reaction (qRT-PCR), western blotting and immunohistochemistry were used to assess expression of LKB1 and Beclin1 in 142 NSCLC tissue samples. The data revealed that expression levels of both LKB1 and Beclin1 mRNA and protein were significantly reduced in the NSCLC tissues compared to levels in the matched surrounding normal lung tissues, and expression of LKB1 protein was associated with Beclin1 expression in the NSCLC tissues. Reduced expression of LKB1 protein was significantly associated with tumor histology (P<0.001) and poor differentiation (P<0.001), but was not associated with tumor lymph node metastasis, TNM stage or patient gender and age, while the reduced expression of Beclin1 protein was associated with tumor histology (P<0.05) and poor differentiation (P<0.05). Univariate analysis revealed that adenocarcinoma, lymph node metastasis, advanced TNM stage and reduced expression of LKB1 and Beclin1 proteins are associated with the survival of NSCLC patients. Multivariate analysis indicated that adenocarcinoma (P<0.05), lymph node metastasis (P<0.05), advanced TNM stage (P<0.001) and reduced expression of LKB1 (P<0.05) and Beclin1 (P<0.001) are all independent prognostic indicators for the survival of NSCLC patients.

View Figures

View References

1	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
2	Hemminki A, Markie D, Tomlinson I, et al: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:184–187. 1998. View Article : Google Scholar : PubMed/NCBI
3	Jenne DE, Reomann H, Nezu J, et al: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 18:38–43. 1998. View Article : Google Scholar : PubMed/NCBI
4	Smith DP, Spicer J, Smith A, Swift S and Ashworth A: The mouse Peutz-Jeghers syndrome gene Lkbl encodes a nuclear protein kinase. Hum Mol Genet. 8:1479–1485. 1999. View Article : Google Scholar : PubMed/NCBI
5	Boudeau J, Kieloch A, Alessi DR, Stella A, Guanti G and Resta N: Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers syndrome patients. Hum Mutat. 21:1722003. View Article : Google Scholar : PubMed/NCBI
6	Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 9:563–575. 2009. View Article : Google Scholar : PubMed/NCBI
7	Kahn BB, Alquier T, Carling D and Hardie DG: AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1:15–25. 2005. View Article : Google Scholar : PubMed/NCBI
8	Baas AF, Boudeau J, Sapkota GP, et al: Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 22:3062–3072. 2003. View Article : Google Scholar : PubMed/NCBI
9	Nakada D, Saunders TL and Morrison SJ: Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature. 468:653–658. 2010. View Article : Google Scholar : PubMed/NCBI
10	Jansen M, Ten Klooster JP, Offerhaus GJ and Clevers H: LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev. 89:777–798. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ji H, Ramsey MR, Hayes DN, et al: LKB1 modulates lung cancer differentiation and metastasis. Nature. 448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
12	Kroemer G, Mariño G and Levine B: Autophagy and the integrated stress response. Mol Cell. 40:280–293. 2010. View Article : Google Scholar : PubMed/NCBI
13	White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
14	Carew JS, Nawrocki ST, Kahue CN, et al: Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
15	Michaud M, Martins I, Sukkurwala AQ, et al: Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science. 334:1573–1577. 2011. View Article : Google Scholar : PubMed/NCBI
16	Moretti L, Yang ES, Kim KW and Lu B: Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist Updat. 10:135–143. 2007. View Article : Google Scholar : PubMed/NCBI
17	Liu YL, Yang PM, Shun CT, Wu MS, Weng JR and Chen CC: Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
18	Choi AM, Ryter SW and Levine B: Autophagy in human health and disease. N Engl J Med. 368:651–662. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wrighton KH: Autophagy: kinase crosstalk through beclin 1. Nat Rev Mol Cell Biol. 14:402–403. 2013. View Article : Google Scholar : PubMed/NCBI
20	Won KY, Kim GY, Kim YW, Song JY and Lim SJ: Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol. 41:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
21	Chen Y, Lu Y, Lu C and Zhang L: Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1α expression. Pathol Oncol Res. 15:487–493. 2009.PubMed/NCBI
22	Ahn CH, Jeong EG, Lee JW, et al: Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 115:1344–1349. 2007. View Article : Google Scholar : PubMed/NCBI
23	Chen N and Karantza V: Autophagy as a therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011. View Article : Google Scholar : PubMed/NCBI
24	Chen S, Rehman SK, Zhang W, Wen A, Yao L and Zhang J: Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta. 1806:220–229. 2010.PubMed/NCBI
25	Alexander A and Walker CL: The role of LKB1 and AMPK in cellular responses to stress and damage. FEBS Lett. 585:952–957. 2011. View Article : Google Scholar : PubMed/NCBI
26	Edge SB and Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
27	Shackelford DB, Abt E, Gerken L, et al: LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell. 23:143–158. 2013. View Article : Google Scholar : PubMed/NCBI
28	Sanchez-Cespedes M, Parrella P, Esteller M, et al: Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62:3659–3662. 2002.PubMed/NCBI
29	Nakada Y, Stewart TG, Peña CG, et al: The LKB1 tumor suppressor as a biomarker in mouse and human tissues. PLoS One. 8:e734492013. View Article : Google Scholar : PubMed/NCBI
30	Matsumoto S, Iwakawa R, Takahashi K, et al: Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene. 26:5911–5918. 2007.
31	Wingo SN, Gallardo TD, Akbay EA, et al: Somatic LKB1 mutations promote cervical cancer progression. PLoS One. 4:e51372009.
32	Su GH, Hruban RH, Bansal RK, et al: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol. 154:1835–1840. 1999.PubMed/NCBI
33	Rowan A, Bataille V, MacKie R, et al: Somatic mutations in the Peutz-Jegners (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol. 112:509–511. 1999. View Article : Google Scholar
34	Nakau M, Miyoshi H, Seldin MF, Imamura M, Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res. 62:4549–4553. 2002.PubMed/NCBI
35	Miyoshi H, Nakau M, Ishikawa TO, Seldin MF, Oshima M and Taketo MM: Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res. 62:2261–2266. 2002.PubMed/NCBI
36	McCarthy A, Lord CJ, Savage K, et al: Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J Pathol. 219:306–316. 2009.
37	Onozato R, Kosaka T, Achiwa H, et al: LKB1 gene mutations in Japanese lung cancer patients. Cancer Sci. 98:1747–1751. 2007. View Article : Google Scholar
38	Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science. 290:1717–1721. 2000. View Article : Google Scholar : PubMed/NCBI
39	Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
40	Liu J, Lin Y, Yang H, Deng Q, Chen G and He J: The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Tumour Biol. 32:1113–1121. 2011. View Article : Google Scholar : PubMed/NCBI
41	Kim KM, Yu TK, Chu HH, et al: Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions. Int J Cancer. 131:E362–E370. 2012. View Article : Google Scholar : PubMed/NCBI